Elsevier

Journal of Hepatology

Volume 70, Issue 4, April 2019, Pages 745-758
Journal of Hepatology

Review
Age and liver transplantation

https://doi.org/10.1016/j.jhep.2018.12.009Get rights and content

Summary

The average age of liver transplant donors and recipients has increased over the years. Independent of the cause of liver disease, older candidates have more comorbidities, higher waitlist mortality and higher post-transplant mortality than younger patients. However, transplant benefit may be similar in older and younger recipients, provided older recipients are carefully selected. The cohort of elderly patients transplanted decades ago is also increasingly raising issues concerning long-term exposure to immunosuppression and aging of the transplanted liver. Excellent results can be achieved with elderly donors and there is virtually no upper age limit for donors after brain death liver transplantation. The issue is how to optimise selection, procurement and matching to ensure good results with elderly donors. The impact of old donor age is more pronounced in younger recipients and patients with a high model for end-stage liver disease score. Age matching between the donor and the recipient should be incorporated into allocation policies with a multistep approach. However, age matching may vary depending on the objectives of different allocation policies. In addition, age matching must be revisited in the era of direct-acting antivirals. More restrictive limits have been adopted in donation after circulatory death. Perfusion machines which are currently under investigation may help expand these limits. In living donor liver transplantation, donor age limit is essentially guided by morbidity related to procurement. In this review we summarise changing trends in recipient and donor age. We discuss the implications of older age donors and recipients. We also consider different options for age matching in liver transplantation that could improve outcomes.

Introduction

The face of liver transplantation has changed in the last decades. Significant improvements have been achieved in terms of post-transplant survival and quality of life. The number of liver transplants performed each year increased up to 2005 in the United States[1], [2] and up to 2010 in Europe,[3], [4], [5], [6] before becoming relatively stable thereafter. The steady increase in donation after circulatory death (DCD) has contributed to the expansion of the donor pool. However, less stringent criteria in the selection of donation after brain death (DBD) donors along with a growing number of DCD donors has not covered the gap between the number of organs and the number of patients who could derive a benefit from transplantation.[7], [8], [9], [10] Due to this imbalance between donors and recipients, there is a clear incentive to push the age limits for donation in liver transplantation. Indeed, good results have been extensively reported with older DBD donors.[11], [12], [13] In the current context of organ shortage, the issue is not whether older donors should be used, rather how to use them and in which recipients.

In parallel with improvements in post-transplant results, more liberal policies have been adopted allowing transplantation as an option in recipients older than 65. The proportion of registrants older than 60 has already increased significantly in the United States and in Europe.[9], [10], [14] Age at registration will probably continue to increase as decompensated hepatitis C virus (HCV)-related cirrhosis represents a lower proportion of candidates, while non-alcoholic steatohepatitis (NASH) has become a leading indication for transplantation.[15], [16] Indeed, patients with decompensated cirrhosis or NASH-related hepatocellular carcinoma (HCC) tend to be older than patients with other causes of liver disease.[10], [17]

The aims of this review are to present and summarise data concerning trends in age at registration for liver transplantation according to different aetiologies, impact of aging in candidates for transplantation and recipients, impact of older donors, interactions between older donors and older recipients and how to optimise the management in this population. This review is based on both a systematic review of the literature and expert opinion.

Section snippets

Trends in epidemiology and corresponding trends in recipients age

The age of liver transplant recipients has increased steadily over the last 15 years in the United States and Europe (Fig. 1A,B). For instance, the proportion of liver transplant recipients aged 65 or more increased from 9% in 2002 to 20% in 2017 in the United States.2 In the Eurotransplant area, there has been a 16% increase in the number of liver transplant recipients aged 65 years or more between 2012 and 2016.6 Similar trends have been observed in the mean age of new registrants for

Aging of the normal liver

The functional impact of aging is less pronounced on the liver than on the kidney or the heart. However, several aspects of the mechanisms involved in aging of the normal liver are important to better understand why donor age matters in liver transplantation.

As the liver ages, it tends to shrink in size with a 20 to 40% volume reduction, more marked in women than in men (Fig. 3). The hepatic arteriolar walls are thicker with a reduction in the endothelial cell fenestration and a decrease in

Lessons learned from kidney transplantation

Because of an organ shortage in kidney transplantation, there has been a trend towards the use of older donors, although it has become evident that kidneys from older donors have reduced functional reserve and graft survival.124 Because older recipients have shorter life expectancy than younger recipients and frequently die with a functional graft, transplant nephrologists have proposed allocation policies including age matching.[125], [126] The aim is to allocate the highest quality grafts to

Age matching between donors and recipients in liver transplantation: A complex issue

The scenario in liver transplantation is much more complex than in kidney transplantation since aging of the liver has less functional consequences. In addition, by contrast to patients with end-stage renal diseases who can be placed on dialysis, no effective artificial liver support exists. So far, in contrast to kidney transplantation, no allocation policy including age matching has been implemented for liver transplantation. Even though good results can be achieved by using old donors in

Conclusions

There is no universal age limit for transplantation but physiological condition including frailty and comorbidities are important to consider in older candidates. Efforts should be made to identify combinations of age, comorbidities and frailty that reduce transplant benefit in older recipients up to the point that transplantation may be futile.

In parallel, the cohort of elderly patients who were transplanted 1 to 3 decades ago is growing and these patients are mainly exposed to non-liver

Financial support

The authors received no financial support to produce this manuscript.

Conflicts of interest

The authors declare no conflicts of interest that pertain to this work.

Please refer to the accompanying ICMJE disclosure forms for further details.

Acknowledgments

The authors are indebted to Dr Vincent Karam who provided ELTR data on donors and recipient’s age in Europe

References (141)

  • K.D. Watt et al.

    Long-term probability of and mortality from de novo malignancy after liver transplantation

    Gastroenterology

    (2009)
  • L.B. VanWagner et al.

    Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations

    Am J Transplant

    (2018)
  • J.C. Lai et al.

    Frailty predicts waitlist mortality in liver transplant candidates

    Am J Transplant

    (2014)
  • J.C. Lai et al.

    Physical frailty after liver transplantation

    Am J Transplant

    (2018)
  • K.D. Watt et al.

    Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study

    Am J Transplant

    (2010)
  • E.S. Dellon et al.

    Impact of dialysis and older age on survival after liver transplantation

    Am J Transplant

    (2006)
  • J.R. Leventhal et al.

    Nonchimeric HLA-identical renal transplant tolerance: regulatory immunophenotypic/genomic biomarkers

    Am J Transplant

    (2016)
  • S. Prenner et al.

    Comprehensive review on colorectal cancer and transplant

    Am J Transplant

    (2017)
  • M. Slawik et al.

    Lipotoxicity, overnutrition and energy metabolism in aging

    Ageing Res Rev

    (2006)
  • N.A. Timchenko

    Aging and liver regeneration

    Trends Endocrinol Metab

    (2009)
  • G.L. Wang et al.

    HDAC1 cooperates with C/EBPalpha in the inhibition of liver proliferation in old mice

    J Biol Chem

    (2008)
  • M. Hoare et al.

    Ageing, telomeres, senescence, and liver injury

    J Hepatol

    (2010)
  • S. He et al.

    Senescence in Health and Disease

    Cell

    (2017)
  • G. Ilyas et al.

    Macrophage autophagy limits acute toxic liver injury in mice through down regulation of interleukin-1beta

    J Hepatol

    (2016)
  • A.D. Aravinthan et al.

    Senescence in chronic liver disease: is the future in aging?

    J Hepatol

    (2016)
  • J.B. Halldorson et al.

    D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching

    Am J Transplant

    (2009)
  • J.H. Hoofnagle et al.

    Donor age and outcome of liver transplantation

    Hepatology

    (1996)
  • A. Rana et al.

    Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation

    Am J Transplant

    (2008)
  • A.E. Braat et al.

    The Eurotransplant donor risk index in liver transplantation: ET-DRI

    Am J Transplant

    (2012)
  • S. Feng et al.

    Characteristics associated with liver graft failure: the concept of a donor risk index

    Am J Transplant

    (2006)
  • P.G. Northup et al.

    Donor factors predicting recipient survival after liver retransplantation: the retransplant donor risk index

    Am J Transplant

    (2007)
  • M. Berenguer et al.

    Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients

    Hepatology

    (2002)
  • T. Darius et al.

    Septuagenarian and octogenarian donors provide excellent liver grafts for transplantation

    Transplant Proc

    (2012)
  • M. Gastaca et al.

    Donors older than 70 years in liver transplantation

    Transplant Proc

    (2005)
  • UNOS. Accessed at: https://unos.org....
  • I. Bilbao et al.

    Our experience in liver transplantation in patients over 65 yr of age

    Clin Transplant

    (2008)
  • Biomédecine. Adl. Accessed at: www.sipg.sante.fr....
  • B.H. Collins et al.

    Long-term results of liver transplantation in older patients 60 years of age and older

    Transplantation

    (2000)
  • Eurotransplant. Accessed at: https://eurotransplant.org....
  • M. Stepanova et al.

    The portrait of an adult liver transplant recipient in the United States from 1987 to 2013

    JAMA Intern Med

    (2014)
  • E.J. Gane et al.

    Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C

    N Engl J Med

    (2013)
  • J.A. Flemming et al.

    Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy

    Hepatology

    (2017)
  • F. Su et al.

    Aging of liver transplant registrants and recipients: trends and impact on waitlist outcomes, post-transplantation outcomes, and transplant-related survival benefit

    Gastroenterology

    (2016)
  • E. Lawitz et al.

    Sofosbuvir for previously untreated chronic hepatitis C infection

    N Engl J Med

    (2013)
  • D. Goldberg et al.

    Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation

    Gastroenterology

    (2017)
  • M. Bhat et al.

    Race and disease etiology predict de novo malignancy risk following liver transplantation: insights for future individualized cancer screening guidance

    Transplantation

    (2018)
  • E. Saez-Gonzalez et al.

    Impact of hepatitis C virus (HCV) antiviral treatment on the need for liver transplantation (LT)

    Liver Int

    (2018)
  • T.J. Cross et al.

    Liver transplantation in patients over 60 and 65 years: an evaluation of long-term outcomes and survival

    Liver Transpl

    (2007)
  • J.J. Schwartz et al.

    Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience

    Liver Transpl

    (2012)
  • S.R. Sharpton et al.

    Combined effects of recipient age and model for end-stage liver disease score on liver transplantation outcomes

    Transplantation

    (2014)
  • Cited by (178)

    View all citing articles on Scopus
    View full text